Amneal Pharmaceuticals, LLC recalls traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Lt…
- Recall date
- March 19, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0408-2026
- FDA classification
- Class II
- Brand / firm
- Amneal Pharmaceuticals, LLC
- Sold / distributed
- Nationwide within the USA
Why it was recalled
Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability (25¿C/60%RH).
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382220, India, Distributed by: Amneal Pharmaceuticals LLC, Glasgow, KY 42141, NDC 60219-2348-5.
Get recall alerts
Free email alert whenever Amneal Pharmaceuticals, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Amneal Pharmaceuticals, LLC